InvestorsHub Logo
icon url

GrthzGd

04/11/14 9:03 AM

#176660 RE: Rocky3 #176658

So TRx up 7.6% wow, while NRx up .4% wow. A mixed picture, but certainly positive for GILD.

N.b., as I learned from 'The Antidote' (where CVS Pharmacy withheld its Incivek prescription reports for several weeks in 2011, causing a double digit drop in VRTX), such reports can be quite inaccurate, or at least lumpy.
icon url

pollyvonwog

04/18/14 1:03 PM

#176974 RE: Rocky3 #176658

Sovaldi: This week's numbers from twitter:

$GILD Sovaldi IMS scripts for the wk ending April 11"

TRx 7,870, -2% w/w (2nd sequential down wk)
NRx 3,645, -6% w/w (3rd sequential down wk)
icon url

Rocky3

05/16/14 8:29 AM

#178017 RE: Rocky3 #176658

From Twitter - this week's numbers in chart form (over 9K TRx for Sovaldi- getting close to to seeing $4B in Q2):

https://twitter.com/H3NPHLO/status/467279079545507840/photo/1